Home
Conditions
Fibrosis

Clinical trial condition

Fibrosis

Explore clinical trials studying Fibrosis. Study availability and eligibility vary by location and protocol.

891 public trials 179 recruiting studies

Refine in advanced search Browse all conditions

Fibrosis trial results

Enrolling by Invitation

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

NCT05285878

Conditions: Behavior, Chronic Disease, Disease Attributes, +24 more
Locations: Houston Methodist Research Institute Houston, Texas, United States

View Trial Details

Enrolling by Invitation

cACLD in Patients With Alcohol Use Disorder in the Hospital Detoxification Unit

NCT06838468

Conditions: Alcohol Abuse/Dependence, Alcohol-Related Disorders, Alcoholism, +9 more
Locations: Consorci Corporació Sanitària Parc Taulí Sabadell, Barcelona, Spain

View Trial Details

Enrolling by Invitation

Non-invasive Methods for Predicting Decompensation of Chronic Liver Disease

NCT06741904

Conditions: Chronic Liver Disease and Cirrhosis, Fibrosis, Pathologic Processes, +1 more
Locations: Nanfang Hospital of Southern Medical University Guangzhou, China

View Trial Details

Enrolling by Invitation

A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis

NCT06671275

Conditions: Cirrhosis Liver, Fibrosis, Pathologic Processes, +1 more
Locations: Lianxin Liu Hefei, Anhui, China

View Trial Details

Enrolling by Invitation

CMR in T2DM: The NSR Cohort

NCT05915260

Conditions: Cardiomyopathies, Cardiovascular Diseases, Cardiovascular Magnetic Resonance Imaging, +14 more
Locations: Slagelse Hospital, department of cardiology and endocrinology, medicine 2 Slagelse, Denmark

View Trial Details

Not Yet Recruiting

Association of Lipoprotein(a) With Postoperative Atrial Fibrillation

NCT07737444

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07704892

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07701993

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PET/MRI of Primary Sclerosing Cholangitis

NCT06252610

Conditions: Fibrosis, PSC, Pathologic Processes, +1 more
Locations: Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School Charlestown, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource Settings

NCT07667608

Conditions: Adenocarcinoma, Ascites, Atrophy, +27 more
Locations: Not specified

View Trial Details

Fibrosis

Fibrosis trial results

Related conditions